Compounds > 1-methyl-4-phenylpyridinium
Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Basal Ganglia Diseases

1-methyl-4-phenylpyridinium has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johannessen, JN1

Reviews

1 review(s) available for 1-methyl-4-phenylpyridinium and Basal Ganglia Diseases

ArticleYear
A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Neurotoxicology, 1991,Summer, Volume: 12, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Basal Ganglia Diseases; Catecholamines; Corpus Striatum; Humans; Models, Neurological; MPTP Poisoning; Neurons; Time Factors

1991